EP1027430A4 - 64 human secreted proteins - Google Patents
64 human secreted proteinsInfo
- Publication number
- EP1027430A4 EP1027430A4 EP98934551A EP98934551A EP1027430A4 EP 1027430 A4 EP1027430 A4 EP 1027430A4 EP 98934551 A EP98934551 A EP 98934551A EP 98934551 A EP98934551 A EP 98934551A EP 1027430 A4 EP1027430 A4 EP 1027430A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- secreted proteins
- human secreted
- human
- proteins
- secreted
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Physics & Mathematics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Biotechnology (AREA)
- Cell Biology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Microbiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Food Science & Technology (AREA)
- Pharmacology & Pharmacy (AREA)
- Analytical Chemistry (AREA)
- Veterinary Medicine (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Peptides Or Proteins (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP03012177A EP1346999A3 (en) | 1997-07-16 | 1998-07-15 | Human secreted protein |
Applications Claiming Priority (41)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US5287297P | 1997-07-16 | 1997-07-16 | |
US5266197P | 1997-07-16 | 1997-07-16 | |
US5287097P | 1997-07-16 | 1997-07-16 | |
US5287597P | 1997-07-16 | 1997-07-16 | |
US5287397P | 1997-07-16 | 1997-07-16 | |
US5287197P | 1997-07-16 | 1997-07-16 | |
US5287497P | 1997-07-16 | 1997-07-16 | |
US52871P | 1997-07-16 | ||
US52875P | 1997-07-16 | ||
US52874P | 1997-07-16 | ||
US52661P | 1997-07-16 | ||
US52872P | 1997-07-16 | ||
US52870P | 1997-07-16 | ||
US52873P | 1997-07-16 | ||
US5344197P | 1997-07-22 | 1997-07-22 | |
US5344297P | 1997-07-22 | 1997-07-22 | |
US5344097P | 1997-07-22 | 1997-07-22 | |
US53440P | 1997-07-22 | ||
US53441P | 1997-07-22 | ||
US53442P | 1997-07-22 | ||
US5598597P | 1997-08-18 | 1997-08-18 | |
US5572497P | 1997-08-18 | 1997-08-18 | |
US5568397P | 1997-08-18 | 1997-08-18 | |
US5595297P | 1997-08-18 | 1997-08-18 | |
US5572697P | 1997-08-18 | 1997-08-18 | |
US5598997P | 1997-08-18 | 1997-08-18 | |
US5594697P | 1997-08-18 | 1997-08-18 | |
US5635997P | 1997-08-18 | 1997-08-18 | |
US5636197P | 1997-08-18 | 1997-08-18 | |
US5572597P | 1997-08-18 | 1997-08-18 | |
US55726P | 1997-08-18 | ||
US55985P | 1997-08-18 | ||
US55683P | 1997-08-18 | ||
US55952P | 1997-08-18 | ||
US56361P | 1997-08-18 | ||
US55989P | 1997-08-18 | ||
US56359P | 1997-08-18 | ||
US55724P | 1997-08-18 | ||
US55725P | 1997-08-18 | ||
US55946P | 1997-08-18 | ||
PCT/US1998/014613 WO1999003990A1 (en) | 1997-07-16 | 1998-07-15 | 64 human secreted proteins |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP03012177A Division EP1346999A3 (en) | 1997-07-16 | 1998-07-15 | Human secreted protein |
Publications (2)
Publication Number | Publication Date |
---|---|
EP1027430A1 EP1027430A1 (en) | 2000-08-16 |
EP1027430A4 true EP1027430A4 (en) | 2001-09-19 |
Family
ID=27586422
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP98934551A Withdrawn EP1027430A4 (en) | 1997-07-16 | 1998-07-15 | 64 human secreted proteins |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP1027430A4 (en) |
JP (1) | JP2003524366A (en) |
AU (1) | AU8404598A (en) |
CA (1) | CA2296815A1 (en) |
WO (1) | WO1999003990A1 (en) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7057017B2 (en) | 1997-04-16 | 2006-06-06 | Millennium Pharmaceuticals, Inc. | Human dickkopf-related protein and nucleic acid molecules and uses therefor |
US7446181B2 (en) | 1998-01-15 | 2008-11-04 | Millennium Pharmaceuticals, Inc. | Antibodies that bind human Dickkopf-1 proteins |
US7258973B2 (en) * | 1998-08-31 | 2007-08-21 | Mayo Foundation For Medical Education & Research | Method for detecting a differentially expressed sequence |
US6344541B1 (en) | 1998-09-25 | 2002-02-05 | Amgen Inc. | DKR polypeptides |
EP1144603A3 (en) * | 1999-01-22 | 2002-02-06 | Memorec Medical Molecular Research Cologne Stoffel GmbH | Protease |
CA2361293A1 (en) * | 1999-02-10 | 2000-08-17 | Human Genome Sciences, Inc. | 33 human secreted proteins |
AU4484400A (en) * | 1999-04-23 | 2000-11-10 | University Of Washington | Prostate-specific polynucleotides, polypeptides and their methods of use |
AU5316800A (en) * | 1999-08-05 | 2001-03-05 | Incyte Genomics, Inc. | Secretory molecules |
KR100543857B1 (en) * | 1999-09-01 | 2006-01-23 | 제넨테크, 인크. | Promote or inhibit angiogenesis and cardiovascularization |
CA2389203A1 (en) * | 1999-09-28 | 2001-04-05 | Incyte Genomics, Inc. | Human secretory molecules |
AU2001266320A1 (en) * | 2000-06-22 | 2002-01-02 | Zoegene Corporation | Gene encoding novel protocadherin-like protein |
CA2443123A1 (en) | 2001-04-10 | 2002-10-24 | Agensys, Inc. | Nuleic acids and corresponding proteins useful in the detection and treatment of various cancers |
US7927597B2 (en) | 2001-04-10 | 2011-04-19 | Agensys, Inc. | Methods to inhibit cell growth |
CA2574881C (en) | 2004-08-04 | 2013-01-08 | Amgen Inc. | Antibodies to dkk-1 |
WO2006015497A1 (en) * | 2004-08-13 | 2006-02-16 | Val-Chum, S.E.C. | Methods of use of a dkk1 protein, immunogenic polypeptides thereof, nucleic acid encoding the dkk1 protein or polypeptides, or ligands thereof for detecting tumors; and for eliciting immune response against tumors |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1995024474A1 (en) * | 1994-03-10 | 1995-09-14 | Human Genome Sciences, Inc. | Bone morphogenic protein-10 |
-
1998
- 1998-07-15 EP EP98934551A patent/EP1027430A4/en not_active Withdrawn
- 1998-07-15 WO PCT/US1998/014613 patent/WO1999003990A1/en not_active Application Discontinuation
- 1998-07-15 JP JP2000503196A patent/JP2003524366A/en not_active Withdrawn
- 1998-07-15 CA CA002296815A patent/CA2296815A1/en not_active Abandoned
- 1998-07-15 AU AU84045/98A patent/AU8404598A/en not_active Abandoned
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1995024474A1 (en) * | 1994-03-10 | 1995-09-14 | Human Genome Sciences, Inc. | Bone morphogenic protein-10 |
Non-Patent Citations (7)
Title |
---|
DATABASE EMBL EMBL; 1 July 1998 (1998-07-01), STRAUSBERG: "ox23f12.s1 Soares_fetal_liver_spleen_1NFLS_S1 Homo sapiens cDNA clone", XP002162614 * |
DATABASE EMBL EMBL; 17 October 1995 (1995-10-17), DODSWORTH ET AL.: "H.sapiens CpG island DNA genomic Mse1 fragment, clone 183a9, forward read", XP002162609 * |
DATABASE EMBL EMBL; 17 October 1995 (1995-10-17), DODSWORTH ET AL.: "H.sapiens CpG island DNA genomic Mse1 fragment, clone 183h4, reverse read", XP002162611 * |
DATABASE EMBL EMBL; 18 October 1995 (1995-10-18), DODSWORTH ET AL.: "H.sapiens CpG island DNA genomic Mse1 fragment, clone 170e10, forward read", XP002162610 * |
DATABASE EMBL EMBL; 27 May 1996 (1996-05-27), MARRA ET AL.: "mc69c06.r1 Soares mouse embryo NbME13.5 14.5 Mus musculus cDNA clone", XP002162612 * |
DATABASE EMBL EMBL; 30 April 1996 (1996-04-30), MARRA ET AL.: "mb25d03.r1 Soares mouse p3NMF19.5 Mus musculus cDNA clone", XP002162613 * |
See also references of WO9903990A1 * |
Also Published As
Publication number | Publication date |
---|---|
EP1027430A1 (en) | 2000-08-16 |
JP2003524366A (en) | 2003-08-19 |
WO1999003990A1 (en) | 1999-01-28 |
CA2296815A1 (en) | 1999-01-28 |
AU8404598A (en) | 1999-02-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1039801A4 (en) | 207 human secreted proteins | |
EP1000084A4 (en) | 123 human secreted proteins | |
EP1040117A4 (en) | 110 human secreted proteins | |
EP1088071A4 (en) | 94 human secreted proteins | |
EP1100869A4 (en) | 98 human secreted proteins | |
AU6552198A (en) | 28 human secreted proteins | |
EP1078046A4 (en) | 97 human secreted proteins | |
EP1109821A4 (en) | 49 human secreted proteins | |
EP1140970A4 (en) | 47 human secreted proteins | |
AU6952998A (en) | 20 human secreted proteins | |
EP1051426A4 (en) | 67 human secreted proteins | |
EP1064297A4 (en) | 95 human secreted proteins | |
EP1005544A4 (en) | 70 human secreted proteins | |
EP1019091A4 (en) | 50 human secreted proteins | |
AU8066998A (en) | 86 human secreted proteins | |
EP1044211A4 (en) | 36 human secreted proteins | |
EP1097199A4 (en) | 71 human secreted proteins | |
EP1115735A4 (en) | 31 human secreted proteins | |
EP1124850A4 (en) | 12 human secreted proteins | |
EP1027430A4 (en) | 64 human secreted proteins | |
EP1032838A4 (en) | 125 human secreted proteins | |
EP1009766A4 (en) | 19 human secreted proteins | |
EP1062236A4 (en) | 31 human secreted proteins | |
EP1159284A4 (en) | 33 human secreted proteins | |
EP1002132A4 (en) | 90 human secreted proteins |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20000208 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE |
|
RIC1 | Information provided on ipc code assigned before grant |
Free format text: 7C 12N 15/11 A, 7C 12N 15/63 B, 7C 12N 15/00 B, 7C 12N 15/12 B, 7A 61K 38/17 B, 7C 07K 16/00 B, 7C 12P 21/02 B, 7C 12Q 1/68 B, 7G 01N 33/68 B, 7C 07K 14/47 B |
|
A4 | Supplementary search report drawn up and despatched |
Effective date: 20010803 |
|
AK | Designated contracting states |
Kind code of ref document: A4 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE |
|
17Q | First examination report despatched |
Effective date: 20030205 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20030616 |